1
|
Elessa D, Grosjean V, Lozeron P, Harel S, Royer B, Forgeard N, Thèves F, Talbot A, Malphettes M, Bengoufa D, Kubis N, Arnulf B. Rituximab with alkylating agent in anti-myelin-associated glycoprotein neuropathy: A retrospective study of 26 cases. Br J Haematol 2024. [PMID: 38500363 DOI: 10.1111/bjh.19412] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2023] [Revised: 03/05/2024] [Accepted: 03/10/2024] [Indexed: 03/20/2024]
Affiliation(s)
- D Elessa
- Service d'Immuno-Hématologie, Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Paris, France
- Université Paris Cité, Paris, France
| | - V Grosjean
- Université Paris Cité, Paris, France
- Service de Physiologie Clinique-Explorations Fonctionnelles, Assistance Publique - Hôpitaux de Paris, Hôpital Lariboisière, Paris, France
| | - P Lozeron
- Université Paris Cité, Paris, France
- Service de Physiologie Clinique-Explorations Fonctionnelles, Assistance Publique - Hôpitaux de Paris, Hôpital Lariboisière, Paris, France
| | - S Harel
- Service d'Immuno-Hématologie, Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Paris, France
- Université Paris Cité, Paris, France
| | - B Royer
- Service d'Immuno-Hématologie, Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Paris, France
- Université Paris Cité, Paris, France
| | - N Forgeard
- Service d'Immuno-Hématologie, Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Paris, France
- Université Paris Cité, Paris, France
| | - F Thèves
- Service d'Immuno-Hématologie, Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Paris, France
- Université Paris Cité, Paris, France
| | - A Talbot
- Service d'Immuno-Hématologie, Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Paris, France
- Université Paris Cité, Paris, France
| | - M Malphettes
- Université Paris Cité, Paris, France
- Service d'Immuno-pathologie Clinique, Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Paris, France
| | - D Bengoufa
- Université Paris Cité, Paris, France
- Laboratoire d'Immunologie, Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Paris, France
| | - N Kubis
- Université Paris Cité, Paris, France
- Service de Physiologie Clinique-Explorations Fonctionnelles, Assistance Publique - Hôpitaux de Paris, Hôpital Lariboisière, Paris, France
| | - B Arnulf
- Service d'Immuno-Hématologie, Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Paris, France
- Université Paris Cité, Paris, France
| |
Collapse
|
2
|
Bastien G, McAnulty C, Ledjiar O, Socias ME, Le Foll B, Lim R, Hassan AN, Brissette S, Marsan S, Talbot A, Jutras-Aswad D. Effects of Buprenorphine/Naloxone and Methadone on Depressive Symptoms in People with Prescription Opioid Use Disorder: A Pragmatic Randomised Controlled Trial. Can J Psychiatry 2023; 68:572-585. [PMID: 36519188 PMCID: PMC10411362 DOI: 10.1177/07067437221145013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
OBJECTIVE This study aimed to evaluate the effectiveness of flexible take-home dosing of buprenorphine/naloxone (BUP/NX) and methadone standard model of care in reducing depressive symptoms in people with prescription-type opioid use disorder (POUD). This trial also evaluated whether improvements in depressive symptoms were mediated by opioid use. METHODS Analyzed data came from the OPTIMA study (clinicaltrials.gov identifier: NCT03033732), a pragmatic randomised controlled trial comparing flexible take-home dosing of BUP/NX and methadone standard model of care for reducing opioid use in people with POUD. A total of 272 participants were recruited in four Canadian provinces. Participants were randomised 1:1 to BUP/NX or methadone. After treatment induction, past two-week opioid use was measured using the Timeline Followback every two weeks for a total of 24 weeks. Depressive symptoms were measured with the Beck Depression Inventory at baseline, weeks 12 and 24. RESULTS Both BUP/NX and methadone significantly reduced depressive symptoms at week 12 (aβ ± SE = -3.167 ± 1.233; P < 0.001) and week 24 (aβ ± SE = -7.280 ± 1.285; P < 0.001), with no interaction between type of treatment and time (P = 0.284). Improvements in depressive symptoms were only partially mediated by a reduction in opioid use (proportion mediated = 36.8%; 95% confidence interval = -1.158 to -0.070; P = 0.015). CONCLUSIONS BUP/NX and methadone showed similar effectiveness in decreasing comorbid depressive symptoms in people with POUD. This effect was partially explained by a reduction in opioid use. As both treatments seem equally effective, clinicians are encouraged to tailor the selection of OAT to patients' needs and characteristics.
Collapse
Affiliation(s)
- Gabriel Bastien
- Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada
- Research Centre, Centre Hospitalier de l’Université de Montréal (CRCHUM), Montréal, Québec, Canada
| | - Christina McAnulty
- Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada
- Research Centre, Centre Hospitalier de l’Université de Montréal (CRCHUM), Montréal, Québec, Canada
| | - Omar Ledjiar
- Unité de recherche clinique appliquée, Centre hospitalier universitaire Ste-Justine, Montréal, Québec, Canada
| | - M. Eugenia Socias
- British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada
- Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
| | - Bernard Le Foll
- Translational Addiction Research Laboratory, Campbell Family Mental Health Research Institute, Center for Addiction and Mental Health, Toronto, Ontario, Canada
- Department of Pharmacology and Toxicology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
- Department of Family and Community Medicine, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
- Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
- Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
- Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario, Canada
| | - Ron Lim
- Department of Medicine and Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Ahmed N. Hassan
- Translational Addiction Research Laboratory, Campbell Family Mental Health Research Institute, Center for Addiction and Mental Health, Toronto, Ontario, Canada
- Department of Pharmacology and Toxicology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
- Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
| | - Suzanne Brissette
- Research Centre, Centre Hospitalier de l’Université de Montréal (CRCHUM), Montréal, Québec, Canada
- Department of Family and Emergency Medicine, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada
| | - Stéphanie Marsan
- Research Centre, Centre Hospitalier de l’Université de Montréal (CRCHUM), Montréal, Québec, Canada
- Department of Family and Emergency Medicine, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada
| | - Annie Talbot
- Research Centre, Centre Hospitalier de l’Université de Montréal (CRCHUM), Montréal, Québec, Canada
- Department of Family and Emergency Medicine, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada
| | - Didier Jutras-Aswad
- Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada
- Research Centre, Centre Hospitalier de l’Université de Montréal (CRCHUM), Montréal, Québec, Canada
| | | |
Collapse
|
3
|
Breton M, Lamoureux-Lamarche C, Deslauriers V, Laberge M, Arsenault J, Gaboury I, Beauséjour M, Pomey MP, Motulsky A, Talbot A, St-Yves A, Smithman MA, Deville-Stoetzel N, Sauvé C, Abou Malham S. Evaluation of the implementation of single points of access for unattached patients in primary care and their effects: a study protocol. BMJ Open 2023; 13:e070956. [PMID: 36868603 PMCID: PMC9990645 DOI: 10.1136/bmjopen-2022-070956] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/05/2023] Open
Abstract
INTRODUCTION Attachment to a primary care provider is an important component of primary care as it facilitates access. In Québec, Canada, attachment to a family physician is a concern. To address unattached patients' barriers to accessing primary care, the Ministry of Health and Social Services mandated Québec's 18 administrative regions to implement single points of access for unattached patients (Guichets d'accès première ligne (GAPs)) that aim to better orient patients towards the most appropriate services to meet their needs. The objectives of this study are to (1) analyse the implementation of GAPs, (2) measure the effects of GAPs on performance indicators and (3) assess unattached patients' experiences of navigation, access and service utilisation. METHODS AND ANALYSIS A longitudinal mixed-methods case study design will be conducted. Objective 1. Implementation will be analysed through semistructured interviews with key stakeholders, observations of key meetings and document analysis. Objective 2. GAP effects on indicators will be measured using performance dashboards produced using clinical and administrative data. Objective 3. Unattached patients' experiences will be assessed using a self-administered electronic questionnaire. Findings for each case will be interpreted and presented using a joint display, a visual tool for integrating qualitative and quantitative data. Intercase analyses will be conducted highlighting the similarities and differences across cases. ETHICS AND DISSEMINATION This study is funded by the Canadian Institutes of Health Research (# 475314) and the Fonds de Soutien à l'innovation en santé et en services sociaux (# 5-2-01) and was approved by the CISSS de la Montérégie-Centre Ethics Committee (MP-04-2023-716).
Collapse
Affiliation(s)
- Mylaine Breton
- Department of community health sciences, Université de Sherbrooke-Campus de Longueuil, Longueuil, Québec, Canada
| | - Catherine Lamoureux-Lamarche
- Department of community health sciences, Université de Sherbrooke-Campus de Longueuil, Longueuil, Québec, Canada
| | - Véronique Deslauriers
- Department of community health sciences, Université de Sherbrooke-Campus de Longueuil, Longueuil, Québec, Canada
| | - Maude Laberge
- Department of social and preventive medicine, Université Laval, Québec, Québec, Canada
- Centre de recherche du CHU de Québec-Université Laval, Québec, Québec, Canada
| | - Josée Arsenault
- Direction de l'accès aux services médicaux de première ligne pour la Montérégie, Centre intégré de santé et de services sociaux de la Montérégie-Centre du Québec, Greenfield Park, Québec, Canada
| | - Isabelle Gaboury
- Department of community health sciences, Université de Sherbrooke-Campus de Longueuil, Longueuil, Québec, Canada
| | - Marie Beauséjour
- Department of community health sciences, Université de Sherbrooke-Campus de Longueuil, Longueuil, Québec, Canada
| | - Marie-Pascale Pomey
- Department of Family Medicine and Emergency Medicine, Université de Montréal École de Santé Publique, Montréal, Québec, Canada
| | - Aude Motulsky
- Department of Management, Evaluation and Health Policy, Université de Montréal École de Santé Publique, Montréal, Québec, Canada
| | - Annie Talbot
- Department of Family Medicine and Emergency Medicine, Université de Montréal, Montréal, Québec, Canada
| | - Annie St-Yves
- Department of community health sciences, Université de Sherbrooke, Sherbrooke, Québec, Canada
| | - Mélanie Ann Smithman
- Department of community health sciences, Université de Sherbrooke-Campus de Longueuil, Longueuil, Québec, Canada
| | - Nadia Deville-Stoetzel
- Department of community health sciences, Université de Sherbrooke-Campus de Longueuil, Longueuil, Québec, Canada
| | - Carine Sauvé
- Direction de l'accès aux services médicaux de première ligne pour la Montérégie, Centre intégré de santé et de services sociaux de la Montérégie-Centre du Québec, Greenfield Park, Québec, Canada
| | - Sabina Abou Malham
- Department of community health sciences, Université de Sherbrooke-Campus de Longueuil, Longueuil, Québec, Canada
| |
Collapse
|
4
|
Ali F, Russell C, Law J, Talbot A, Elton-Marshall T, Bozinoff N, Imtiaz S, Rehm J, Giang V, Rush B. Withdrawal Management Practices and Services in Canada: A Cross-Sectional National Survey on the Management of Opioid Use Disorder. Canadian Journal of Addiction 2023. [DOI: 10.1097/cxa.0000000000000167] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/03/2023]
|
5
|
Bouabida K, Malas K, Talbot A, Desrosiers MÈ, Lavoie F, Lebouché B, Taguemout M, Rafie E, Lessard D, Pomey MP. Remote Patient Monitoring Program for COVID-19 Patients Following Hospital Discharge: A Cross-Sectional Study. Front Digit Health 2021; 3:721044. [PMID: 34859244 PMCID: PMC8630581 DOI: 10.3389/fdgth.2021.721044] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2021] [Accepted: 09/30/2021] [Indexed: 11/13/2022] Open
Abstract
Background: The COVID-19 pandemic created an urgent need to act to reduce the spread of the virus and alleviate congestion from healthcare services, protect healthcare providers, and help them maintain satisfactory quality and safety of care. Remote COVID-19 monitoring platforms emerged as potential solutions. Objective: The purpose of this study was to evaluate the capacity and contribution of two different platforms used to remotely monitor patients with COVID-19 to maintain quality, safety, and patient engagement in care, as well as their acceptability, usefulness, and user-friendliness from the user's perspective. The first platform is focused on telecare phone calls (Telecare-Covid), and the second is a telemonitoring app (CareSimple-Covid). Methods: We performed a cross-sectional study. The data were collected through a phone survey from May to August 2020. Data were analyzed using descriptive statistics and t-test analysis. Participants' responses and comments on open-ended questions were analyzed using content analysis to identify certain issues and challenges and potential avenues for improving the platforms. Results: Fifty one patients participated in the study. Eighteen participants used the CareSimple-Covid platform and 33 participants used the Telecare-Covid platform. Overall, the satisfaction rate for quality and safety of care for the two platforms was 80%. Over 88% of the users on each platform considered the platforms' services to be engaging, useful, user-friendly, and appropriate to their needs. The survey identified a few significant differences in users' perceptions of each platform: empathy toward users and the quality and safety of the care received were rated significantly higher on the CareSimple-Covid platform than on the Telecare-Covid platform. Users appreciated four aspects of these telehealth approaches: (1) the ease of access to services and the availability of care team members; (2) the user-friendliness of the platforms; (3) the continuity of care provided, and (4) the wide range of services delivered. Users identified some technical limitations and raised certain issues, such as the importance of maintaining human contact, data security, and confidentiality. Improvement suggestions include promoting access to connected devices; enhancing communications between institutions, healthcare users, and the public on confidentiality and personal data protection standards; and integrating a participatory approach to telehealth platform development and deployment efforts. Conclusion: This study provides preliminary evidence that the two remote monitoring platforms are well-received by users, with very few significant differences between them concerning users' experiences and views. This type of program could be considered for use in a post-pandemic era and for other post-hospitalization clienteles. To maximize efficiency, the areas for improvement and the issues identified should be addressed with a patient-centered approach.
Collapse
Affiliation(s)
- Khayreddine Bouabida
- University of Montreal Hospital Centre de Recherche du Centre Hospitalier Universitaire de Montréal (CRCHUM), Montreal, QC, Canada.,École de Santé publique, Département de Gestion, Université de Montréal, Montreal, QC, Canada
| | - Kathy Malas
- Excutive Office, Centre Hospitalier Universitaire de Montréal (CHUM), Montreal, QC, Canada.,Département de Recherche, Montreal Cancer Institute, University of Montreal Hospital Centre (CRCHUM), Montreal, QC, Canada.,Innovation Axis, Research Center of the CHUM, Montreal, QC, Canada
| | - Annie Talbot
- Innovation Axis, Research Center of the CHUM, Montreal, QC, Canada.,Network Coordination Department, CHUM, Montreal, QC, Canada
| | - Marie-Ève Desrosiers
- Innovation Axis, Research Center of the CHUM, Montreal, QC, Canada.,Network Coordination Department, CHUM, Montreal, QC, Canada
| | - Frédéric Lavoie
- Innovation Axis, Research Center of the CHUM, Montreal, QC, Canada.,Network Coordination Department, CHUM, Montreal, QC, Canada
| | - Bertrand Lebouché
- Canadian Institutes of Health Research Strategy for Patient-Oriented Research Mentorship Chair in Innovative Clinical Trials in Human Immunodeficiency Virus (HIV), Montreal, QC, Canada.,Centre for Outcomes Research and Evaluation, McGill University Health Centre Research Institute, Montreal, QC, Canada
| | - Melissa Taguemout
- Innovation Axis, Research Center of the CHUM, Montreal, QC, Canada.,State-of-the-Art Technology and Methods, Montreal, QC, Canada
| | - Edmond Rafie
- Innovation Axis, Research Center of the CHUM, Montreal, QC, Canada.,State-of-the-Art Technology and Methods, Montreal, QC, Canada
| | - David Lessard
- Canadian Institutes of Health Research Strategy for Patient-Oriented Research Mentorship Chair in Innovative Clinical Trials in Human Immunodeficiency Virus (HIV), Montreal, QC, Canada.,Centre for Outcomes Research and Evaluation, McGill University Health Centre Research Institute, Montreal, QC, Canada
| | - Marie-Pascale Pomey
- Département de Recherche, Montreal Cancer Institute, University of Montreal Hospital Centre (CRCHUM), Montreal, QC, Canada.,State-of-the-Art Technology and Methods, Montreal, QC, Canada.,Center of Excellence of Patient Partnership and the Public, Montreal, QC, Canada.,Department of Health Management, Evaluation, and Policy, School of Public Health, Université de Montréal, Montreal, QC, Canada
| |
Collapse
|
6
|
Talbot A, McCabe M, Daly B, Gallagher D. Heart Rate Variability-Guided Exercise During Chemotherapy in Triathlete with Stage 1 BRCA1-Mutated Breast Cancer. Ir Med J 2021; 114:420. [PMID: 35476380] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Affiliation(s)
- A Talbot
- Royal College of Surgeons in Ireland, Dublin
| | - M McCabe
- Sports Med Ireland, 32 Kildare St, Dublin
| | - B Daly
- Sports Med Ireland, 32 Kildare St, Dublin
| | - D Gallagher
- Mater Private Hospital, Eccles Street, Dublin
- St. James' Hospital, James' Street, Dublin
| |
Collapse
|
7
|
Talbot A, Jaccard A, Arnulf B. [POEMS syndrome: Diagnosis, stratification, treatments]. Rev Med Interne 2021; 42:320-329. [PMID: 33678446 DOI: 10.1016/j.revmed.2021.02.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2020] [Revised: 12/22/2020] [Accepted: 02/06/2021] [Indexed: 10/22/2022]
Abstract
POEMS syndrome is a rare form of B-cell dyscrasia with multiple clinical signs including the acronym for polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes. It is a paraneoplastic syndrome due to an underlying plasma cell disorder belonging to the monoclonal gammopathies of clinical significance (MGCS). The major criteria for this syndrome are polyradiculoneuropathy, clonal plasma cell disorder (PCD), sclerotic bone lesions, elevated vascular endothelial growth factor (VEGF), and the presence of Castleman's disease. Minor features include organomegaly, endocrinopathy, skin changes, papilledema, extravascular volume over-load, and thrombocytosis. The diagnosis of POEMS syndrome requires three of the major criteria, two of which must include polyradiculoneuropathy and clonal PCD, and at least one of the minor criteria. VEGF plays a major role in the disease although anti-VEGF treatments have been disappointing. Risk stratification is based on clinical phenotype rather than specific molecular markers. Depending on bone marrow involvement and the number of sclerotic bone lesions, first line therapy should be irradiation or systemic therapy. For patients with a dominant sclerotic plasmacytoma, first line therapy is irradiation. Patients with diffuse sclerotic lesions or disseminated bone marrow involvement and for those who have progression of their disease 3 to 6 months after completing irradiation therapy should receive antiplasma cell systemic therapy, the most effective being high dose chemotherapy with autologous stem cell transplantation. Lenalidomide seems to have a high efficacy with manageable toxicity. Thalidomide and proteasome inhibitors like bortezomib are also effective, but their benefit needs to be weighed against their risk of exacerbating the peripheral neuropathy.
Collapse
Affiliation(s)
- A Talbot
- Service d'immuno-hématologie, Hôpital Saint-Louis, AP-HP, Paris, France, Université de Paris, Paris, France; Inserm, UMR 976, Institut de Recherche Saint-Louis, Université de Paris, Paris, France.
| | - A Jaccard
- Service d'Hématologie et de Thérapie Cellulaire, CHU Limoges, France; Centre de Référence des Amyloses Primitives et des Autres Maladies par Dépôts d'Immunoglobuline, CHU Limoges, France
| | - B Arnulf
- Service d'immuno-hématologie, Hôpital Saint-Louis, AP-HP, Paris, France, Université de Paris, Paris, France; Inserm, UMR 976, Institut de Recherche Saint-Louis, Université de Paris, Paris, France
| |
Collapse
|
8
|
Talbot A, Devos L, Dubus F, Vermandel M. Multimodal imaging in radiotherapy: Focus on adaptive therapy and quality control. Cancer Radiother 2020; 24:411-417. [PMID: 32517893 DOI: 10.1016/j.canrad.2020.04.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2020] [Revised: 04/23/2020] [Accepted: 04/24/2020] [Indexed: 12/16/2022]
Abstract
Improved computer resources in radiation oncology department have greatly facilitated the integration of multimodal imaging into the workflow of radiation therapy. Nowadays, physicians have highly informative imaging modalities of the anatomical region to be treated. These images contribute to the targeting accuracy with the current treatment device, impacting both segmentation or patient's positioning. Additionally, in a constant effort to deliver personalized care, many teams seek to confirm the benefits of adaptive radiotherapy. The published works highlight the importance of registration algorithms, particularly those of elastic or deformable registration necessary to take into account the anatomical evolutions of the patients during the course of their therapy. These algorithms, often considered as "black boxes", tend to be better controlled and understood by physicists and physicians thanks to the generalization of evaluation and validation methods. Given the still significant development of medical imaging techniques, it is foreseeable that multimodal registration needs require more efficient algorithms well integrated within the flow of data.
Collapse
Affiliation(s)
- A Talbot
- Medical Physics Department, CHU de Lille, 59037 Lille, France; Neurosurgery Department, hôpital Roger-Salengro, CHU de Lille, 59037 Lille, France
| | - L Devos
- Neurosurgery Department, hôpital Roger-Salengro, CHU de Lille, 59037 Lille, France; Nuclear Medicine Department, hôpital Roger-Salengro, CHU de Lille, 59037 Lille, France
| | - F Dubus
- Medical Physics Department, CHU de Lille, 59037 Lille, France; Neurosurgery Department, hôpital Roger-Salengro, CHU de Lille, 59037 Lille, France
| | - M Vermandel
- Medical Physics Department, CHU de Lille, 59037 Lille, France; Neurosurgery Department, hôpital Roger-Salengro, CHU de Lille, 59037 Lille, France; Nuclear Medicine Department, hôpital Roger-Salengro, CHU de Lille, 59037 Lille, France; Université de Lille, 59000 Lille, France; Inserm, U1189, 59000 Lille, France; ONCO-THAI-Image-Assisted Laser Therapy for Oncology, CHU de Lille, 59000 Lille, France.
| |
Collapse
|
9
|
Dangien A, Beylot-Barry M, Battistella M, Ram-Wolff C, Talbot A, Rybojad M, Vergier B, Jachiet M, Bouaziz JD, Arnulf B, Bagot M, De Masson A. Association lymphome B cutané primitif de la zone marginale et amyloses cutanées. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.414] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
10
|
Talbot A, Holt S, Quinlan C, Trainer A, Winship I, Nicholls K. SUN-205 Inherited Renal Disease at the Royal Melbourne Hospital – Prevalence, Impact and Benefit of a Specialist Renal Genetics Clinic. Kidney Int Rep 2019. [DOI: 10.1016/j.ekir.2019.05.608] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
11
|
Talbot A, Thomas M, Nicholls K, Ritchie D, Szer J, Carnley B, Morynko A, Sturm M, Fallet S, Kreher N. SAT-102 AUTOLOGOUS STEM CELL THERAPY USING LENTIVIRAL VECTOR FOR TREATMENT OF FABRY DISEASE. Kidney Int Rep 2019. [DOI: 10.1016/j.ekir.2019.05.129] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
12
|
Button B, Wilson L, Finlayson F, Talbot A, Burge A, Wilson J. P232 The Alfred Wellness Score (AweScore) in adults with cystic fibrosis: stability, validity and response to pulmonary exacerbations. J Cyst Fibros 2019. [DOI: 10.1016/s1569-1993(19)30525-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
13
|
Pourcher V, Breillat P, Deshayes S, Michel P, Angelard B, Arnulf B, Talbot A, Buob D, Grateau G, Georgin-Lavialle S. Amylose et VIH : étude française multicentrique et revue de la littérature. Med Mal Infect 2019. [DOI: 10.1016/j.medmal.2019.04.095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
14
|
Finlayson F, Talbot A, Wilson J. P421 The Adult Cystic fibrosis Experience (ACE) Score: a short, patient-reported experience measure (PREM) for cystic fibrosis care. J Cyst Fibros 2019. [DOI: 10.1016/s1569-1993(19)30713-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
15
|
Dangien A, Beylot‐Barry M, Battistella M, Ram‐Wolff C, Talbot A, Rybojad M, Vergier B, Jachiet M, Bouaziz J, Arnulf B, Bagot M, Masson A. Clinical presentation, therapeutic approach and outcome of primary cutaneous marginal zone B‐cell lymphoma presenting as AL amyloidoma of the skin. Br J Dermatol 2019; 181:607-609. [DOI: 10.1111/bjd.17821] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- A. Dangien
- Departments of Dermatology Saint‐Louis Hospital APHP Paris France
| | - M. Beylot‐Barry
- Departments of Dermatology Saint‐André Hospital CHU de Bordeaux INSERM U1053 Université de Bordeaux Bordeaux France
| | - M. Battistella
- Departments of Pathology Saint‐Louis Hospital APHP Paris France
- INSERM U976 Université Paris 7 Paris France
| | - C. Ram‐Wolff
- Departments of Dermatology Saint‐Louis Hospital APHP Paris France
| | - A. Talbot
- Departments of Immuno‐hematology Saint‐Louis Hospital APHP Paris France
| | - M. Rybojad
- Departments of Dermatology Saint‐Louis Hospital APHP Paris France
| | - B. Vergier
- Departments of Pathology Saint‐André Hospital CHU de Bordeaux INSERM U1053 Université de Bordeaux Bordeaux France
| | - M. Jachiet
- Departments of Dermatology Saint‐Louis Hospital APHP Paris France
| | - J.‐D. Bouaziz
- Departments of Dermatology Saint‐Louis Hospital APHP Paris France
- INSERM U976 Université Paris 7 Paris France
| | - B. Arnulf
- Departments of Immuno‐hematology Saint‐Louis Hospital APHP Paris France
| | - M. Bagot
- Departments of Dermatology Saint‐Louis Hospital APHP Paris France
- INSERM U976 Université Paris 7 Paris France
| | - A. Masson
- Departments of Dermatology Saint‐Louis Hospital APHP Paris France
- INSERM U976 Université Paris 7 Paris France
| |
Collapse
|
16
|
Roupie AL, Battistella M, Talbot A, Jachiet M, Bouaziz JD, Vignon-Pennamen MD, Royer B, Fermand JP, Arnulf B, Harel S. Coexisting cutaneous macroglobulinosis and scleredema of Buschke in a patient with a Waldenström Macroglobulinemia. J Eur Acad Dermatol Venereol 2018; 33:e104-e106. [PMID: 30267590 DOI: 10.1111/jdv.15268] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- A L Roupie
- Department of Immuno-Hematology, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Louis, 1 avenue Claude Vellefaux, 75010, Paris, France
| | - M Battistella
- Department of Pathology, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Louis, 1 avenue Claude Vellefaux, 75010, Paris, France.,Groupe d'Etude des Dermatoses associées à une Immunoglobuline Monoclonale (GEDIM), Hôpital Saint-Louis, 1 avenue Claude Vellefaux, 75010, Paris, France
| | - A Talbot
- Department of Immuno-Hematology, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Louis, 1 avenue Claude Vellefaux, 75010, Paris, France.,Groupe d'Etude des Dermatoses associées à une Immunoglobuline Monoclonale (GEDIM), Hôpital Saint-Louis, 1 avenue Claude Vellefaux, 75010, Paris, France
| | - M Jachiet
- Groupe d'Etude des Dermatoses associées à une Immunoglobuline Monoclonale (GEDIM), Hôpital Saint-Louis, 1 avenue Claude Vellefaux, 75010, Paris, France.,Department of Dermatology, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Louis, 1 avenue Claude Vellefaux, 75010, Paris, France
| | - J D Bouaziz
- Groupe d'Etude des Dermatoses associées à une Immunoglobuline Monoclonale (GEDIM), Hôpital Saint-Louis, 1 avenue Claude Vellefaux, 75010, Paris, France.,Department of Dermatology, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Louis, 1 avenue Claude Vellefaux, 75010, Paris, France
| | - M D Vignon-Pennamen
- Department of Pathology, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Louis, 1 avenue Claude Vellefaux, 75010, Paris, France.,Groupe d'Etude des Dermatoses associées à une Immunoglobuline Monoclonale (GEDIM), Hôpital Saint-Louis, 1 avenue Claude Vellefaux, 75010, Paris, France
| | - B Royer
- Department of Immuno-Hematology, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Louis, 1 avenue Claude Vellefaux, 75010, Paris, France.,Groupe d'Etude des Dermatoses associées à une Immunoglobuline Monoclonale (GEDIM), Hôpital Saint-Louis, 1 avenue Claude Vellefaux, 75010, Paris, France
| | - J P Fermand
- Department of Immuno-Hematology, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Louis, 1 avenue Claude Vellefaux, 75010, Paris, France.,Groupe d'Etude des Dermatoses associées à une Immunoglobuline Monoclonale (GEDIM), Hôpital Saint-Louis, 1 avenue Claude Vellefaux, 75010, Paris, France
| | - B Arnulf
- Department of Immuno-Hematology, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Louis, 1 avenue Claude Vellefaux, 75010, Paris, France.,Groupe d'Etude des Dermatoses associées à une Immunoglobuline Monoclonale (GEDIM), Hôpital Saint-Louis, 1 avenue Claude Vellefaux, 75010, Paris, France
| | - S Harel
- Department of Immuno-Hematology, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Louis, 1 avenue Claude Vellefaux, 75010, Paris, France.,Groupe d'Etude des Dermatoses associées à une Immunoglobuline Monoclonale (GEDIM), Hôpital Saint-Louis, 1 avenue Claude Vellefaux, 75010, Paris, France
| |
Collapse
|
17
|
Taylor-Rowan M, Quinn T, Smith P, Ellis G, Keir R, McAlpine C, Marsh G, Murtagh J, McElroy M, Mitchell L, Waddell G, Williams A, Duffy L, Oswald S, Myles A, Bann A, Rodger K, Reid J, Kellichan L, Docharty D, Marshall T, McGurn B, Ritchie C, Wells A, Talbot A, McInnes C, Reynish E, Coleman D, Flynn B, Scott A, Coull A, Dingwall L. 53ASSESSING THE PSYCHOMETRIC PROPERTIES OF THE HIS “THINK FRAILTY” TOOL. Age Ageing 2018. [DOI: 10.1093/ageing/afy127.02] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
| | - T Quinn
- New Lister Building, Glasgow Royal Infirmary
| | - P Smith
- New Lister Building, Glasgow Royal Infirmary
| | - G Ellis
- New Lister Building, Glasgow Royal Infirmary
| | - R Keir
- New Lister Building, Glasgow Royal Infirmary
| | - C McAlpine
- New Lister Building, Glasgow Royal Infirmary
| | - G Marsh
- New Lister Building, Glasgow Royal Infirmary
| | - J Murtagh
- New Lister Building, Glasgow Royal Infirmary
| | - M McElroy
- New Lister Building, Glasgow Royal Infirmary
| | - L Mitchell
- New Lister Building, Glasgow Royal Infirmary
| | - G Waddell
- New Lister Building, Glasgow Royal Infirmary
| | - A Williams
- New Lister Building, Glasgow Royal Infirmary
| | - L Duffy
- New Lister Building, Glasgow Royal Infirmary
| | - S Oswald
- New Lister Building, Glasgow Royal Infirmary
| | - A Myles
- New Lister Building, Glasgow Royal Infirmary
| | - A Bann
- New Lister Building, Glasgow Royal Infirmary
| | - K Rodger
- New Lister Building, Glasgow Royal Infirmary
| | - J Reid
- New Lister Building, Glasgow Royal Infirmary
| | - L Kellichan
- New Lister Building, Glasgow Royal Infirmary
| | - D Docharty
- New Lister Building, Glasgow Royal Infirmary
| | - T Marshall
- New Lister Building, Glasgow Royal Infirmary
| | - B McGurn
- New Lister Building, Glasgow Royal Infirmary
| | - C Ritchie
- New Lister Building, Glasgow Royal Infirmary
| | - A Wells
- New Lister Building, Glasgow Royal Infirmary
| | - A Talbot
- New Lister Building, Glasgow Royal Infirmary
| | - C McInnes
- New Lister Building, Glasgow Royal Infirmary
| | - E Reynish
- New Lister Building, Glasgow Royal Infirmary
| | - D Coleman
- New Lister Building, Glasgow Royal Infirmary
| | - B Flynn
- New Lister Building, Glasgow Royal Infirmary
| | - A Scott
- New Lister Building, Glasgow Royal Infirmary
| | - A Coull
- New Lister Building, Glasgow Royal Infirmary
| | - L Dingwall
- New Lister Building, Glasgow Royal Infirmary
| |
Collapse
|
18
|
Breillat P, Georgin Lavialle S, Deshayes S, Michel P, Molina J, Buob D, Fabiani B, Ballester M, Angelard B, Arnulf B, Talbot A, Grateau G. Amyloses associées à l’infection par le VIH : à propos de 23 cas dont 3 français et 20 issus de la littérature. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.336] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
19
|
Wilson J, Talbot A, Finlayson F, Allen-Graham J, Clark D, Williams E, Kotsimbos T, Keating D. IPD2.12 Treatment with Orkambi™ in Phe508del homozygous CF patients is associated with improvement in cognition. J Cyst Fibros 2018. [DOI: 10.1016/s1569-1993(18)30296-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
20
|
Terre A, Talbot A, Picque J, Hanslik T, Mahevas M, Boutboul D, Grateau G, Georgin Lavialle S. Le syndrome périodique fébrile associé à des arthralgies et une gammapathie monoclonale : un nouveau syndrome auto-inflammatoire ? Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.352] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
21
|
Talbot A. Best imaging modality for femoral trochlear ridge osteochondrosis. EQUINE VET EDUC 2018. [DOI: 10.1111/eve.12721] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- A. Talbot
- Philip Leverhulme Equine Hospital; University of Liverpool; Neston Cheshire UK
| |
Collapse
|
22
|
ElNaggar A, Coffman C, Talbot A, Baum S, Tillmanns T. Radiofrequency ablation for the treatment of recurrent gynecological malignancies: A case series. Gynecol Oncol 2017. [DOI: 10.1016/j.ygyno.2017.03.425] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
23
|
Button B, Wilson L, Kimmell L, Holland A, Finlayson F, Williams E, Talbot A, Keating D, Wilson J. WS08.3 Reliability of the Alfred Wellness Score (AweScore) for use in adults with CF. J Cyst Fibros 2017. [DOI: 10.1016/s1569-1993(17)30203-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
24
|
Collins SE, Grant PM, Uwinkindi F, Talbot A, Seruyange E, Slamowitz D, Mugeni A, Remera E, Niyonsenga SP, Nyirimigabo J, Uwizihiwe JP, Dongier P, Muhayimpundu R, Mazarati JB, Zolopa A, Nsanzimana S. A Randomized Switch From Nevirapine-Based Antiretroviral Therapy to Single Tablet Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in Virologically Suppressed Human Immunodeficiency Virus-1-Infected Rwandans. Open Forum Infect Dis 2016; 3:ofw141. [PMID: 27704000 PMCID: PMC5047400 DOI: 10.1093/ofid/ofw141] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2016] [Accepted: 06/23/2016] [Indexed: 12/12/2022] Open
Abstract
There is a need to improve antiretroviral options in Africa. This study shows switching from a neviripine-based treatment to co-formulated rilpivirine/emtricitabine/tenofovir disoproxil fumarate in virologically suppressed Rwandans is safe and non-inferior to continued nevirapine-based therapy at 24 weeks. Background. Many human immunodeficiency virus (HIV)-infected patients remain on nevirapine-based antiretroviral therapy (ART) despite safety and efficacy concerns. Switching to a rilpivirine-based regimen is an alternative, but there is little experience with rilpivirine in sub-Saharan Africa where induction of rilpivirine metabolism by nevirapine, HIV subtype, and dietary differences could potentially impact efficacy. Methods. We conducted an open-label noninferiority study of virologically suppressed (HIV-1 ribonucleic acid [RNA] < 50 copies/mL) HIV-1-infected Rwandan adults taking nevirapine plus 2 nucleos(t)ide reverse-transcriptase inhibitors. One hundred fifty participants were randomized 2:1 to switch to coformulated rilpivirine-emtricitabine-tenofovir disoproxil fumarate (referenced as the Switch Arm) or continue current therapy. The primary efficacy endpoint was HIV-1 RNA < 200 copies/mL at week 24 assessed by the US Food and Drug Administration Snapshot algorithm with a noninferiority margin of 12%. Results. Between April and September 2014, 184 patients were screened, and 150 patients were enrolled; 99 patients switched to rilpivirine-emtricitabine-tenofovir, and 51 patients continued their nevirapine-based ART. The mean age was 42 years and 43% of participants were women. At week 24, virologic suppression (HIV-1 RNA level <200 copies/mL) was maintained in 93% and 92% in the Switch Arm versus the continuation arm, respectively. The Switch Arm was noninferior to continued nevirapine-based ART (efficacy difference 0.8%; 95% confidence interval, −7.5% to +12.0%). Both regimens were generally safe and well tolerated, although 2 deaths, neither attributed to study medications, occurred in participants in the Switch Arm. Conclusions. A switch from nevirapine-based ART to rilpivirine-emtricitabine-tenofovir disoproxil fumarate had similar virologic efficacy to continued nevirapine-based ART after 24 weeks with few adverse events.
Collapse
Affiliation(s)
- Sean E Collins
- Department of Medicine , Stanford University , California
| | - Philip M Grant
- Department of Medicine , Stanford University , California
| | - Francois Uwinkindi
- Institute of HIV Disease Prevention and Control , Rwanda Biomedical Center , Kigali
| | - Annie Talbot
- Department of Family Medicine , University of Montreal , Ontario , Canada
| | | | | | | | - Eric Remera
- Institute of HIV Disease Prevention and Control , Rwanda Biomedical Center , Kigali
| | | | - Josbert Nyirimigabo
- Institute of HIV Disease Prevention and Control , Rwanda Biomedical Center , Kigali
| | - Jean Paul Uwizihiwe
- Institute of HIV Disease Prevention and Control , Rwanda Biomedical Center , Kigali
| | - Pierre Dongier
- Institute of HIV Disease Prevention and Control , Rwanda Biomedical Center , Kigali
| | | | | | - Andrew Zolopa
- Department of Medicine, Stanford University, California; Viiv Healthcare, Research Triangle Park, North Carolina
| | - Sabin Nsanzimana
- Institute of HIV Disease Prevention and Control , Rwanda Biomedical Center , Kigali
| |
Collapse
|
25
|
Talbot A, Uwihoreye C, Kamen C, Grant P, McGlynn L, Mugabe I, Nshimyumukiza M, Dongier P, Slamowitz D, Padilla C, Uvamahoro J, Musayidire I, Mukarubuga A, Zolopa A. Treating psychological trauma among Rwandan orphans is associated with a reduction in HIV risk-taking behaviors: A pilot study. AIDS Educ Prev 2013; 25:468-479. [PMID: 24245594 DOI: 10.1521/aeap.2013.25.6.468] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
The nongovernmental organization, Uyisenga N'Manzi (UNM), provides Rwandan orphans of genocide and HIV/AIDS with education, social, and mental health services. Many orphans in UNM report symptoms of psychological trauma. The primary study objective was to evaluate a multidisciplinary program integrating HIV prevention with an existing package of mental health services. We randomly selected 120 orphans between ages 15-25 years served by UNM and evaluated sexually-transmitted infections, HIV risk-taking behaviors and knowledge, and mental health at baseline, 5, 9, and 12 months. Increased trauma symptoms at baseline were associated with poorer coping skills and social functioning, and increased psychological distress and HIV risk-taking behavior. Following the 12-month intervention, trauma symptoms declined significantly, with those accessing counseling services showing greatest improvement. Orphans with the highest trauma scores benefited most from the intervention. In this at-risk population, addressing mental health issues in the context of HIV prevention is critical.
Collapse
|
26
|
Hill E, Whitehead M, MacInnes B, Ellis G, Talbot A, Brodie F, Hughes N, Beggs S, Barber M. The first 100 thrombolysis cases in a novel Scottish mesh telestroke system. Scott Med J 2013; 58:213-6. [DOI: 10.1177/0036933013507868] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Stroke thrombolysis has been a major driver for change within stroke services. However, until recently its widespread application has been limited to tertiary centres. Transfer to tertiary care can lead to significant delays in thrombolysis. We developed a novel mesh telestroke network, which allows stroke specialists to make videoconference-based thrombolysis decisions either from one of three stroke units or from home. We report data on the first 100 patients treated using this model and retrospectively review the first 100 strokes thrombolysed with tissue plasminogen activator across three stroke units. Prospectively collected data were extracted from the Stroke Audit In Lanarkshire database. Case notes were retrieved for clarification when necessary. Outcome measures were timings from symptom onset to infusion, post-thrombolysis symptomatic intracerebral haemorrhage and death. Fifty-one percent of cases were assessed by telestroke link. Median symptom onset to thrombolysis was 160 min (IQR 125–190). There were two symptomatic intracerebral haemorrhages, both in patients assessed face-to-face. Overall mortality was 14%. Our experience of tissue plasminogen activator is comparable to UK data extracted from SITS-MOST in overall timings and complication rates. This model of telemedicine could be replicated to provide safe thrombolysis to areas with challenging infrastructure, geography or insufficient stroke specialist cover.
Collapse
Affiliation(s)
- E Hill
- Specialty Trainee in Geriatric Medicine, West of Scotland Rotation, UK
| | - M Whitehead
- Consultant Geriatrician, NHS Lanarkshire, UK
| | - B MacInnes
- Consultant Geriatrician, NHS Lanarkshire, UK
| | - G Ellis
- Consultant Geriatrician, NHS Lanarkshire, UK
| | - A Talbot
- Consultant Geriatrician, NHS Lanarkshire, UK
| | - F Brodie
- Consultant Geriatrician, NHS Lanarkshire, UK
| | - N Hughes
- Consultant Geriatrician, NHS Glasgow and Clyde, UK
| | - S Beggs
- Core Medical Trainee, West of Scotland Rotation, UK
| | - M Barber
- Consultant Geriatrician, NHS Lanarkshire, UK
| |
Collapse
|
27
|
Kupersztych-Hagege E, Teboul JL, Artigas A, Talbot A, Sabatier C, Richard C, Monnet X. Bioreactance is not reliable for estimating cardiac output and the effects of passive leg raising in critically ill patients. Br J Anaesth 2013; 111:961-6. [PMID: 23985531 DOI: 10.1093/bja/aet282] [Citation(s) in RCA: 80] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
Abstract
BACKGROUND Bioreactance estimates cardiac output in a non-invasive way. We evaluated the ability of a bioreactance device (NICOM®) to estimate cardiac index (CI) and to track relative changes induced by volume expansion. METHODS In 48 critically ill patients, we measured CI estimated by the NICOM® device (CINicom) and by transpulmonary thermodilution (CItd, PiCCO2™ device) before and after a 500 ml saline infusion. Before volume expansion, we performed a passive leg raising (PLR) test and measured the changes it induced in CINicom and in pulse contour analysis-derived CI. RESULTS Considering the values recorded before PLR and before and after volume expansion (n=144), the bias (lower and upper limits of agreement) between CItd and CINicom was 0.9 (-2.2 to 4.1) litre min(-1) m(-2). The percentage error was 82%. There was no significant correlation between the changes in CItd and CINicom induced by volume expansion (P=0.24). An increase in CI estimated by pulse contour analysis >9% during the PLR test predicted fluid responsiveness with a sensitivity of 84% (95% confidence interval 60-97%) and a specificity of 97% (95% confidence interval 82-100%). The area under the receiver operating characteristic curve constructed to test the ability of the PLR-induced changes in CINicom in predicting fluid responsiveness did not differ significantly from 0.5 (P=0.77). CONCLUSIONS The NICOM® device cannot accurately estimate the cardiac output in critically ill patients. Moreover, it could not predict fluid responsiveness through the PLR test.
Collapse
Affiliation(s)
- E Kupersztych-Hagege
- Hôpitaux universitaires Paris-Sud, Hôpital de Bicêtre, service de réanimation médicale, 78, rue du Général Leclerc, F-94270 Le Kremlin-Bicêtre, France
| | | | | | | | | | | | | |
Collapse
|
28
|
Gagné F, André C, Turcotte P, Gagnon C, Sherry J, Talbot A. A comparative toxicogenomic investigation of oil sand water and processed water in rainbow trout hepatocytes. Arch Environ Contam Toxicol 2013; 65:309-323. [PMID: 23515748 DOI: 10.1007/s00244-013-9888-2] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/26/2012] [Accepted: 02/24/2013] [Indexed: 06/01/2023]
Abstract
The purpose of this study was to compare the expression of gene transcripts involved in toxic stress in rainbow trout hepatocytes exposed to oil sand water (OSW), lixiviate (OSLW), and processed water (OSPW). We pose the hypothesis that the changes in gene expression responses in cells exposed to a simulated oil sand extraction procedure (OSPW) differ from the gene expression responses of OSLW and OS. Rainbow trout hepatocytes were exposed to increasing concentrations of OSW, OSLW, and OSPW for 48 h at 15 °C. Cell viability was assessed by measuring membrane permeability, total RNA levels, and gene expression using an array of 16 genes involved in xenobiotic biotransformation (GST, CYP1A1, CYP3A4, MDR), metal homeostasis and oxidative stress (MT, SOD, and CAT), estrogenicity (VTG, ERβ), DNA repair (LIG, APEX, UNG, and OGG), cell growth (GADD45 and PCNA), and glycolysis (GAPDH). The results showed that the toxicogenomic properties of OSPW differed from those of OSLW and OSW. Gene transcripts that were influenced by OSW and OSLW, and strongly expressed in OSPW, were MT, CAT, GST (induction), CYP1A1, VTG, UNG/OGG, and PCNA. These genes are therefore considered not entirely specific to OSPW but to water in contact with OS. We also found gene transcripts that responded only with OSPW: SOD, GST (inhibition), MDR (inhibition), CYP3A4, GAPDH, GADD45, and APEX. Of these gene transcripts, the ones strongly associated with toxicity (loss of cell viability and RNA levels) were CYP3A4, GST, and GAPDH. Genes involved in DNA repair were also strongly related to the loss of cell viability but responded to both OSLW and OSPW. The observed changes in cell toxicity and gene expression therefore support the hypothesis that OSPW has a distinct toxic fingerprint from OSLW and OSW.
Collapse
Affiliation(s)
- F Gagné
- Emerging Methods, Aquatic Contaminants Research Division, Water Science and Technology, Environment Canada, 105 Mc Gill Street, Montreal, QC, H2Y 2E7, Canada.
| | | | | | | | | | | |
Collapse
|
29
|
Cillán-García E, Milner PI, Talbot A, Tucker R, Hendey F, Boswell J, Reardon RJM, Taylor SE. Deep digital flexor tendon injury within the hoof capsule; does lesion type or location predict prognosis? Vet Rec 2013; 173:70. [PMID: 23736518 DOI: 10.1136/vr.101512] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
The type and location of deep digital flexor tendon (DDFT) lesions may be important in predicting outcome. The objectives of this study were to determine the frequency of different types of DDFT lesions within the hoof capsule and to determine whether lesion type predicts return to athletic activity. Lesions of the DDFT were divided into: core lesions, dorsal border lesions and parasagittal splits. Lesion location was documented, and follow-up information was obtained by telephone survey at least 18 months after diagnosis. Of 168 horses with primary DDFT injury, 54 horses had dorsal border lesions, 59 had parasagittal splits and 55 had core lesions. Twenty-five per cent of all horses returned to previous levels of athletic activity within 18 months of MRI evaluation. Horses with complete splits or core lesions of the DDFT were significantly less likely to return to some level of athletic activity than horses with dorsal border lesions P<0.001. Dorsal border lesions of the DDFT appear to have a better prognosis than core lesions or parasagittal splits. This study provides additional information that may help clinicians predict the prognosis for different types of DDFT injury.
Collapse
Affiliation(s)
- E Cillán-García
- Department of Veterinary Clinical Sciences, University of Edinburgh, Easter Bush Veterinary Centre, Roslin, Midlothian, UK.
| | | | | | | | | | | | | | | |
Collapse
|
30
|
Gagné F, Douville M, André C, Debenest T, Talbot A, Sherry J, Hewitt LM, Frank RA, McMaster ME, Parrott J, Bickerton G. Differential changes in gene expression in rainbow trout hepatocytes exposed to extracts of oil sands process-affected water and the Athabasca River. Comp Biochem Physiol C Toxicol Pharmacol 2012; 155:551-9. [PMID: 22251623 DOI: 10.1016/j.cbpc.2012.01.004] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/15/2011] [Revised: 01/04/2012] [Accepted: 01/05/2012] [Indexed: 11/30/2022]
Abstract
The oil sands region of northern Alberta represents the world's largest reserves of bitumen, and the accelerated pace of industrial extraction activity has raised concern about the possible impacts on the Athabasca River and its tributaries. An ecotoxicogenomic study was undertaken on Oncorhynchus mykiss trout hepatocytes exposed to extracts of water samples near the oil sand development area, as well as to oil sands process-affected water (OSPW) extracts using the quantitative reverse transcriptase polymerase chain reaction technique. The expression of the following genes (mRNA) was monitored to track changes in xenobiotic biotransformation (CYP1A1, CYP3A4, glutathione S-transferase, multi-drug resistance transporter), estrogenicity (estrogen receptor and vitellogenin), oxidative stress (superoxide dismutase and metallothionein) and DNA repair activity (DNA ligase). The extent of DNA-aromatic hydrocarbon adducts was also determined in cells by immuno-staining. A comparative analysis of gene expression between the river/lake and OSPW samples revealed that CYP3A4, metallothioneins, DNA ligase and GST genes, were specifically expressed by OSPW. Cells exposed to OSPW, commercial naphthenic acids, and benzo(a)pyrene showed increased polyaromatic hydrocarbon DNA-adducts, as determined by cell immunofluorescence analysis. Other genes were induced by all types of water samples, although the induction potential was stronger in OSPW most of the time (e.g., VTG gene was expressed nearly 15-fold by surface waters from the lake and river samples but increased to a maximum of 31-fold in OSPW). A multivariate discriminant function analysis revealed that the lake and river water samples were well discriminated from the OSPW. The CYP3A4 gene was the most highly expressed gene in cells exposed to OSPW and responded less to the lake or river water in the Athabasca River area. This study identified a suite of gene targets that responded specifically to OSPW extracts, which could serve as toxicogenomic fingerprints of OSPW contamination.
Collapse
Affiliation(s)
- F Gagné
- Fluvial Ecosystem Research, Aquatic Ecosystem Protection Division, Water Science and Technology, Environment Canada, 105 McGill Street, Montréal, Quebec, Canada H2Y 2E7.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Klein MB, Baril JG, Charron MA, Fortin C, Lalonde R, Matte MF, Poliquin M, Talbot A, Therrien R, Tremblay C, Trottier B, Tsarevsky I, Villeneuve JP. Management and treatment of hepatitis B virus in patients with HIV infection: A practical guide for health care professionals. Can J Infect Dis Med Microbiol 2011; 22:88-96. [PMID: 22942885 PMCID: PMC3200371 DOI: 10.1155/2011/686918] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
The management and treatment of HIV and hepatitis B virus (HBV)-coinfected patients present specific challenges for clinicians. The morbidity and mortality related to these concomitant infections are growing concerns, while the use of antiviral drugs effective against both viruses complicates therapeutic decision making. The present document provides guidelines for physicians regarding care and treatment of patients coinfected with HIV and HBV. Primary prevention of HBV in HIV-positive patients is achieved through appropriate vaccination schedules. Follow-up before treatment of HBV may include liver biopsy, screening for hepatocellular carcinoma and testing for esophageal varicies in cases of cirrhosis. In HBV-infected patients requiring treatment, recommendations regarding initiation, duration and choice of first-line drugs are made. Finally, in the case of resistance, appropriate alternative therapies are necessary.
Collapse
Affiliation(s)
- Marina B Klein
- Division of Infectious Diseases and Immunodeficiency Service, McGill University Health Centre
| | - Jean-Guy Baril
- Clinique médicale du Quartier Latin
- Unité hospitalière de recherche, d’enseignement et de soins sur le sida, Centre hospitalier de l’Université de Montréal, Hôpital Saint-Luc
- Service de lutte contre les infections transmissibles sexuellement et par le sang, ministère de la Santé et des Services sociaux
| | - Marc-André Charron
- Clinique médicale du Quartier Latin
- Unité hospitalière de recherche, d’enseignement et de soins sur le sida, Centre hospitalier de l’Université de Montréal, Hôpital Saint-Luc
| | - Claude Fortin
- Unité hospitalière de recherche, d’enseignement et de soins sur le sida, Centre hospitalier de l’Université de Montréal, Hôpital Notre-Dame
| | - Richard Lalonde
- Division of Infectious Diseases and Immunodeficiency Service, McGill University Health Centre
| | | | - Marc Poliquin
- Unité hospitalière de recherche, d’enseignement et de soins sur le sida, Centre hospitalier de l’Université de Montréal, Hôpital Notre-Dame
| | - Annie Talbot
- Clinique médicale du Quartier Latin
- Unité hospitalière de recherche, d’enseignement et de soins sur le sida, Centre hospitalier de l’Université de Montréal, Hôpital Saint-Luc
| | - Rachel Therrien
- Unité hospitalière de recherche, d’enseignement et de soins sur le sida, Centre hospitalier de l’Université de Montréal, Hôpital Hôtel-Dieu de Montréal
| | - Cécile Tremblay
- Unité hospitalière de recherche, d’enseignement et de soins sur le sida, Centre hospitalier de l’Université de Montréal, Hôpital Hôtel-Dieu de Montréal
- Association des médecins microbiologistes infectiologues du Québec
| | - Benoît Trottier
- Unité hospitalière de recherche, d’enseignement et de soins sur le sida, Centre hospitalier de l’Université de Montréal, Hôpital Saint-Luc
- Clinique médicale L’Actuel, Montréal
| | - Irina Tsarevsky
- Service de lutte contre les infections transmissibles sexuellement et par le sang, ministère de la Santé et des Services sociaux
| | | |
Collapse
|
32
|
Gagné F, André C, Douville M, Talbot A, Parrott J, McMaster M, Hewitt M. An examination of the toxic properties of water extracts in the vicinity of an oil sand extraction site. ACTA ACUST UNITED AC 2011; 13:3075-86. [DOI: 10.1039/c1em10591d] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
33
|
Gagné F, Blaise C, Pellerin J, Fournier M, Gagnon C, Sherry J, Talbot A. Impacts of pollution in feral Mya arenaria populations: the effects of clam bed distance from the shore. Sci Total Environ 2009; 407:5844-5854. [PMID: 19698974 DOI: 10.1016/j.scitotenv.2009.07.007] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/24/2009] [Revised: 06/30/2009] [Accepted: 07/07/2009] [Indexed: 05/28/2023]
Abstract
This study examined the relationships between population characteristics and the expression of physiological biomarkers of stress in an intertidal clam population under pollution at sites differing in thermal history and coastline distance. The clam population metrics were age distribution, growth, condition factor, distance of the clam beds from the shore, and gonad development. Physiological biomarkers comprised biomarkers of defence such as superoxide dismutase, labile IIb metals in tissues, redox status of metallothioneins and glutathione S-transferase, of tissue damage such as lipid peroxidation and DNA strand breaks, of reproduction as determined by vitellogenin-like proteins and gonadosomatic index and immunocompetence such as phagocytosis and hemocyte viability. Age-related pigments were also examined to compare the physiological age of the clams with their chronological age. The results showed that all the above biomarkers were significantly affected at one of the two polluted sites at least. Distance from the shore was significantly correlated with most (81%) of the biomarkers examined. Clams collected at one polluted site were physiologically older than clams from the corresponding reference site. Canonical and adaptive regression (artificial neural networks) analyses found that the biomarkers measured in this study were able to predict the ecologically relevant endpoints. Biomarkers implicated in defense mechanisms, tissue damage and age-related pigments were most closely related to the clam population characteristics. Sensitivity analysis of the learning algorithm found that the following physiological and biochemical markers were the most predictive, in decreasing order, of clam population characteristics: glutathione S-transferase, phagocytosis, age pigments, lipid peroxidation in the gills, labile IIb metals and total MT levels. These biomarkers were affected by the distance of the clam beds from the shore, site quality (pollution) and reproduction activity.
Collapse
Affiliation(s)
- F Gagné
- Fluvial Ecosystem Research Section, Environment Canada, 105 McGill Street, Montréal, Quebec, Canada.
| | | | | | | | | | | | | |
Collapse
|
34
|
Grant PM, Palmer S, Bendavid E, Talbot A, Slamowitz DC, Cain P, Kobayashi SS, Balamane M, Zolopa AR. Switch from enfuvirtide to raltegravir in virologically suppressed HIV-1 infected patients: effects on level of residual viremia and quality of life. J Clin Virol 2009; 46:305-8. [PMID: 19819183 DOI: 10.1016/j.jcv.2009.09.025] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2009] [Revised: 09/16/2009] [Accepted: 09/19/2009] [Indexed: 02/01/2023]
Abstract
BACKGROUND Raltegravir is a potential treatment option for virologically suppressed HIV-1 infected patients on enfuvirtide with injection site reactions. OBJECTIVES To characterize safety and efficacy of an enfuvirtide to raltegravir switch including changes in T-cells, quality of life, and residual viremia. STUDY DESIGN In patients with viral load <50 copies/mL and injection site reactions, enfuvirtide was switched to raltegravir without additional changes to the antiretroviral regimen. Virologic failure was defined as a viral load >1000 copies/mL or two consecutive viral load measurements between 50 and 1000 copies/mL (low-level viremia). Over the 24 week study, we compared changes in T-cells, injection site reactions, quality of life, and residual viremia, as measured through the single-copy assay which can detect plasma virus down to a single copy, using paired t-tests. RESULTS Fourteen patients with a median CD4+ T-cell count of 420 cells/microL were enrolled. After the switch, two patients experienced virologic failure due to confirmed low-level viremia. However, both patients subsequently were re-suppressed, one without any changes to his regimen. There was no change in CD4+ T-cell count. Injection site reactions resolved. However, there was little reported change in quality of life. The baseline median level of residual viremia was 6 copies/mL and did not change after the switch to raltegravir. CONCLUSIONS A switch to raltegravir in virologically suppressed patients on enfuvirtide is effective in maintaining immunologic and virologic control at 24 weeks but did not result in a change in residual viremia.
Collapse
Affiliation(s)
- Philip M Grant
- Stanford University, Division of Infectious Diseases, Palo Alto, CA 94305-5107, USA.
| | | | | | | | | | | | | | | | | |
Collapse
|
35
|
|
36
|
Gagné F, Blaise C, Pellerin J, Fournier M, Durand MJ, Talbot A. Relationships between intertidal clam population and health status of the soft-shell clam Mya arenaria in the St. Lawrence Estuary and Saguenay Fjord (Québec, Canada). Environ Int 2008; 34:30-43. [PMID: 17825412 DOI: 10.1016/j.envint.2007.06.010] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/21/2007] [Revised: 06/20/2007] [Accepted: 06/21/2007] [Indexed: 05/17/2023]
Abstract
The purpose of this study was to examine the impacts of anthropogenic activity on the health status of intertidal clam populations of the Saguenay Fjord and the St. Lawrence Estuary (Québec, Canada). Clams were collected during low tide at sites subject to direct contamination and at sites far from human activity. Clams were analyzed for tributyltin and dibutyltin total levels and toxic stress (glutathione S-transferase, gonadal lipid peroxidation and DNA strand breaks), immunocompetence (phagocytic activity, hemocyte count and viability), reproduction (gonado-somatic index, gamete maturation, and vitellogenin-like proteins), energy status (temperature-dependent mitochondrial electron transport, and gonad lipids), and individual status (age, condition factor, and growth index). These responses were compared against population characteristics such as live clam density, number of empty shells, and sex ratio. The results show that clam density decreased with distance from the estuary (high salinity level) to upstream of the fjord (low salinity). There was no clear relationship between the number of empty shells and distance or site quality. Clam density values corrected against distance were significantly correlated with hemocyte viability, phagocytic activity, mitochondrial electron transport (MET), DNA damage in gonad, and temperature-dependent mitochondrial electron transport activity. A canonical analysis of the various groups of biomarkers revealed that population metrics were more strongly related with immunocompetence, followed by energy status and temperature-dependent mitochondrial electron transport activity. However, toxic stress biomarkers were strongly associated with energy status and reproduction. This was further confirmed by non-linear modeling using adaptive artificial neural networks (genetic selection and back propagation learning paradigms), where the following parameters were able to predict population parameters with <20% error: gonad maturation and somatic index, MET (at 4 degrees C), gonad LPO, DNA damage, and phagocytic capacity. Intertidal clam populations were influenced by a distance gradient effect (salinity), where immunocompetence, in addition to energy status, was the strongest physiological parameter related to clam population metrics.
Collapse
Affiliation(s)
- F Gagné
- Fluvial Ecosystems Research, Aquatic Ecosystems Research Protection Branch, Environment Canada, 105 McGill Street, Montréal, Québec, Canada H2Y 2E7.
| | | | | | | | | | | |
Collapse
|
37
|
Skotnicki T, Monfray S, Chanemougame D, Coronel P, Harrison S, Dutartre D, Talbot A, Fenouillet-Beranger C, Borel S. SON (Silicon On Nothing) PLATFORM FOR ULSI ERA: TECHNOLOGY&DEVICES. Frontiers in Electronics 2006. [DOI: 10.1142/9789812773081_0009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Affiliation(s)
- T. Skotnicki
- ST Microelectronics, 850, rue J.Monnet, 38921 Crolles, France
| | - S. Monfray
- ST Microelectronics, 850, rue J.Monnet, 38921 Crolles, France
| | - D. Chanemougame
- ST Microelectronics, 850, rue J.Monnet, 38921 Crolles, France
| | - P. Coronel
- ST Microelectronics, 850, rue J.Monnet, 38921 Crolles, France
| | - S. Harrison
- ST Microelectronics, 850, rue J.Monnet, 38921 Crolles, France
| | - D. Dutartre
- ST Microelectronics, 850, rue J.Monnet, 38921 Crolles, France
| | - A. Talbot
- ST Microelectronics, 850, rue J.Monnet, 38921 Crolles, France
| | | | - S. Borel
- CEA-LETI, rue des Martyrs, 38054 Grenoble, France
| |
Collapse
|
38
|
Talbot A, Kitchener JA. Diffusion (or conduction) along a slightly tapering tube, and its application to the determination of diffusion coefficients. ACTA ACUST UNITED AC 2002. [DOI: 10.1088/0508-3443/7/3/304] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
39
|
Pate GE, Curtin R, Talbot A, Murphy RT, Ward D, Barry M, Crean P, Foley JB, Walsh MJ. Audit of acute myocardial infarctions at Saint James's Hospital, Dublin, from 1996 to 1999. Ir Med J 2002; 95:274-6. [PMID: 12469999] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/27/2023]
Abstract
Saint James' Hospital is a 650-bed tertiary referral hospital. An audit was performed of acute transmural myocardial infarctions for the years 1996 to 1999 inclusive. On average there were 2043 cardiology admissions annually, 9.8% of all hospital admissions. Acute transmural myocardial infarction was diagnosed in 178 patients annually, and was less common during the summer. The figure of 72% receiving revascularisation therapy (thrombolysis 67%, primary angioplasty 5%) compares favourably with 35% in 1992. The main reason for not receiving thrombolysis was late presentation (15%) with contraindications present in only 5%. The case fatality rate was 16% confirming the higher mortality in clinical practice than that of thrombolytic trials. The prescription of aspirin or warfarin (99%) and betablockers (67%) was in line with international trials. The use of angiotensin converting enzyme inhibitors (34%) and statins (28%) is similar to other studies but less than would be expected according to trial evidence.
Collapse
Affiliation(s)
- G E Pate
- Department of Cardiology, CResT Directorate, Saint James' Hospital, Dublin 8
| | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Abstract
Adrenal phaeochromocytoma rarely causes ectopic ACTH syndrome. We describe a 44-yr-old hypertensive woman who was Cushingoid and markedly pigmented. Laboratory studies indicated severe hypokalaemia, abnormal liver function tests, and random serum cortisols greater than 1660 nmol/L. Urinary catecholamines were markedly increased. An abdominal computed tomography scan showed a 4-cm left adrenal mass and an hypertrophied right adrenal. ACTH levels were elevated at 200 pmol/L, but ACTH precursors, which cross-react in the ACTH assay, were more highly elevated at 1625 pmol/L. The tumor cells cultured in vitro also secreted ACTH precursors, whereas ACTH levels were undetectable. Because the patient was highly pigmented, we measured circulating concentrations of alpha-MSH, which were undetectable and certainly insufficient to stimulate melanogenesis, suggesting that tumorderived ACTH precursors or ACTH were responsible for the pigmentation. A laparoscopic adrenalectomy resulted in remission of the Cushing's syndrome and dramatic reduction in the pigmentation. Before operation, treatment of the patient with metyrapone and replacement dexamethasone decreased cortisol from more than 1660 to less than 20 nmol/L. Surprisingly, this resulted in a decrease in ACTH precursors to 100 pmol/L and ACTH to 9.0 pmol/L. In vitro treatment of the tumor cells with dexamethasone for 24 or 40 h increased ACTH precursor secretion. In summary, this phaeochromocytoma causing Cushing's syndrome secreted primarily ACTH precursors, which seemed to cause the marked pigmentation. In vivo and in vitro evidence suggests that glucocorticoids induced ACTH precursor secretion.
Collapse
Affiliation(s)
- A White
- Endocrine Sciences Research Group, Faculty of Medicine and School of Biological Sciences, University of Manchester, Manchester M13 9PT, United Kingdom.
| | | | | | | | | | | |
Collapse
|
41
|
Abstract
OBJECTIVE The cause of pediatric chronic sinusitis is multifactorial, but nasal edema appears to be the initial pathologic step. The objective of this study is to evaluate gastronasal reflux as a possible cause of pediatric sinusitis. METHODS Thirty children with chronic sinusitis were believed to be appropriate candidates for functional endoscopic sinus surgery. Children were evaluated retrospectively for their response to reflux therapy with regard to their sinus symptoms and avoidance of sinus surgery. RESULTS Two of the 30 children were eventually excluded because they were taken to surgery for the specific purpose of contact point release. Chart review at 24-month follow-up indicated that 25 of the 28 children (89%) avoided sinus surgery. CONCLUSION After reflux treatment, the number of children requiring sinus surgery was dramatically reduced. The results of this preliminary pediatric study indicate that gastronasal reflux should be evaluated and treated before sinus surgical intervention.
Collapse
Affiliation(s)
- M R Bothwell
- Division of Otolaryngology, University of Missouri-Columbia, USA
| | | | | | | | | |
Collapse
|
42
|
Abstract
The two-dimensional position of markers in radiographs for Roentgen Stereophotogrammetric Analysis (RSA) is usually determined using a measuring table. The purpose of this study was to evaluate the reproducibility and the accuracy of a new RSA system using digitized radiographs and image-processing algorithms to determine the marker position in the radiographs. Four double-RSA examinations of a phantom and 18 RSA examinations from six patients included in different RSA-studies of knee prostheses were used to test the reproducibility and the accuracy of the system. The radiographs were scanned at 600 dpi resolution and 256 gray levels. The center of each of the tantalum-markers in the radiographs was calculated by the computer program from the contour of the marker with the use of an edge-detection software algorithm after the marker was identified on a PC monitor. The study showed that computer-based image analysis can be used in RSA-examinations. The advantages of using image-processing software in RSA are that the marker positions are determined in an objective manner, and that there is no need for a systematic manual identification of all the markers on the radiograph before the actual measurement.
Collapse
Affiliation(s)
- S E Ostgaard
- Department of Orthopedics, National University Hospital, Copenhagen, Denmark
| | | | | | | | | | | |
Collapse
|
43
|
Abstract
A dynamic model of oxygen transport through the outer skin layers and a polarographic sensor was developed for the analysis of transcutaneous oxygen tension (tcPO2). It provides a basis for quantifying the factors that determine the relationship between tcPO2 and arterial oxygen tension (PaO2). Model simulations show the importance of stratum papillare metabolic oxygen consumption; the oxygen permeability of the skin relative to that of the sensor membrane and electrolyte; and temperature and the oxyhemoglobin dissociation curve. These simulations were consistent with experimental data obtained by using microcathode transcutaneous oxygen sensors, which were placed on the skin of 10 healthy adults. Furthermore, the model indicates that accurate evaluation of arterial oxygen tension by using transcutaneous measurements requires continuous estimation of skin perfusion. On the basis of tcPO2 measurements made during arterial occlusion, simulations indicate that quantitative evaluation of the metabolic oxygen consumption of the viable skin tissues is possible only when the oxygen permeabilities of the skin and sensor are known.
Collapse
Affiliation(s)
- A Talbot
- Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH 44106-7207, USA
| | | | | | | |
Collapse
|
44
|
Meyer BJ, Russo C, Talbot A. Discourse comprehension and problem solving: decisions about the treatment of breast cancer by women across the life span. Psychol Aging 1995. [PMID: 7779321 DOI: 10.1037//0882-7974.10.1.84] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
The 1st study examined the decision making and prose comprehension of 94 women interacting with an authentic, unfolding health scenario about breast cancer. The 2nd study involved questionnaire data focusing on the decisions made by 75 women who had been diagnosed with breast cancer. Two major findings emerged from this laboratory and survey research. First, older women sought less information when making treatment decisions about breast cancer. However, the outcome of those decisions were equivalent to those of younger women. Second, older women made these decisions faster than younger women. In addition, treatment decisions were related to prose processing, the type of information underlined as important while reading as well as the type of information remembered about various treatment options.
Collapse
Affiliation(s)
- B J Meyer
- Department of Educational Psychology, Pennsylvania State University, University Park 16802-3109, USA
| | | | | |
Collapse
|
45
|
Meyer BJ, Russo C, Talbot A. Discourse comprehension and problem solving: decisions about the treatment of breast cancer by women across the life span. Psychol Aging 1995; 10:84-103. [PMID: 7779321 DOI: 10.1037/0882-7974.10.1.84] [Citation(s) in RCA: 86] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
The 1st study examined the decision making and prose comprehension of 94 women interacting with an authentic, unfolding health scenario about breast cancer. The 2nd study involved questionnaire data focusing on the decisions made by 75 women who had been diagnosed with breast cancer. Two major findings emerged from this laboratory and survey research. First, older women sought less information when making treatment decisions about breast cancer. However, the outcome of those decisions were equivalent to those of younger women. Second, older women made these decisions faster than younger women. In addition, treatment decisions were related to prose processing, the type of information underlined as important while reading as well as the type of information remembered about various treatment options.
Collapse
Affiliation(s)
- B J Meyer
- Department of Educational Psychology, Pennsylvania State University, University Park 16802-3109, USA
| | | | | |
Collapse
|
46
|
Abstract
A vestibular schwannoma in an only hearing ear is a difficult management problem. A case is presented of a patient who had a Nucleus-22 channel device implanted into a nonfunctioning ear and auditory rehabilitation prior to resection of a large vestibular schwannoma in the contralateral ear.
Collapse
Affiliation(s)
- A Talbot
- Department of Otology and Neuro-Otology, St Vincents Hospital, Darlinghurst, Sydney, NSW, Australia
| | | | | | | |
Collapse
|
47
|
López Ramírez GM, Rom WN, Ciotoli C, Talbot A, Martiniuk F, Cronstein B, Reibman J. Mycobacterium tuberculosis alters expression of adhesion molecules on monocytic cells. Infect Immun 1994; 62:2515-20. [PMID: 7910594 PMCID: PMC186539 DOI: 10.1128/iai.62.6.2515-2520.1994] [Citation(s) in RCA: 49] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Abstract
The host response to Mycobacterium tuberculosis is characterized by interactions between mononuclear cells, with recruitment and fusion of these cells culminating in granuloma formation. In addition, the host response to M. tuberculosis requires CD4+ T-cell reactivity, mediated by antigen-independent as well as antigen-dependent mechanisms. Thus, we hypothesized that cell adhesion molecules such as intercellular adhesion molecule 1 (ICAM-1; CD54) would participate in the response to infection with M. tuberculosis. Exposure of THP-1 cells derived from a monocyte/macrophage cell line to M. tuberculosis (1:1 bacterium/cell ratio) elicited a sustained increase (660% +/- 49% above resting level) in the expression of ICAM-1 that continued for at least 72 h. Neither the expression of vascular cell adhesion molecule 1 (VCAM-1; CD106) nor that of the integrins lymphocyte function-associated antigen 1 (LFA-1; CD11a/CD18) or CR3 (CD11b/CD18) was increased to a similar extent at corresponding time points. The increase in ICAM-1 protein expression was accompanied by an increase in steady-state mRNA (Northern [RNA] analysis). Neutralizing monoclonal antibodies directed against tumor necrosis factor alpha but not interleukin 1 alpha or interleukin 1 beta substantially abrogated the response to M. tuberculosis consistent with a paracrine or autocrine response. Continuous upregulation of the expression of ICAM-1 on mononuclear phagocytes induced by M. tuberculosis may mediate the recruitment of monocytes and enhance the antigen presentation of M. tuberculosis, thus permitting the generation and maintenance of the host response.
Collapse
Affiliation(s)
- G M López Ramírez
- Division of Pulmonary and Critical Care Medicine, Bellevue Hospital, New York
| | | | | | | | | | | | | |
Collapse
|
48
|
Hviid L, Albeck G, Hansen B, Theander TG, Talbot A. A new portable device for automatic controlled-gradient cryopreservation of blood mononuclear cells. J Immunol Methods 1993; 157:135-42. [PMID: 8423356 DOI: 10.1016/0022-1759(93)90079-m] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
Protection of the functional integrity of mononuclear cells stored in liquid N2 requires careful control of the freezing procedure. Consequently, optimal quality of cryopreserved cells is usually assured by freezing according to a specified time-temperature gradient generated by computer-controlled freezing devices. While such equipment offers large capacity and secures maximum survival and functional integrity of the lymphocytes upon thawing, it is quite costly and strictly stationary. We have previously developed and tested an alternative, manual device for controlled-gradient lymphocyte freezing, which has proved suitable for field conditions. We report here the development and testing of a similar micro-controller regulated device, allowing unattended and automatic controlled-gradient cell freezing. The equipment exploits the temperature gradient present between the liquid N2 surface and the neck in an ordinary liquid N2 refrigerator. The lymphocyte samples are placed in a small elevator, which is moved through the N2 gas phase by a stepper motor. Time and temperature are measured at regular intervals, and the position of the samples adjusted to ensure that the actual measurements closely match encoded ideal values. Results of assays of the functional integrity and phenotypic composition of human mononuclear cells frozen by the new system were comparable to those obtained when using cells frozen by a commercially available, stationary cell-freezing equipment, or fresh autologous cell samples tested in parallel. Furthermore, there was a good correlation between functional and phenotypic data obtained using frozen and autologous fresh samples of mononuclear cells. The equipment described is low weight and has low N2 consumption, and is thus suitable for the collection and cryopreservation of lymphocytes under field conditions. Furthermore, the technique provides an inexpensive alternative for researchers with a limited requirement for the simultaneous freezing of large quantities of cells.
Collapse
Affiliation(s)
- L Hviid
- Centre for Medical Parasitology, University of Copenhagen, Denmark
| | | | | | | | | |
Collapse
|
49
|
Sone T, Talbot A, Harada T, Ikuo T, Kato T, Uematsu H. The effects of 24% paraquat (1,1'-dimethyl-4,4'-bipyridylium dichloride) on hemodynamics, blood gases, plasma lactate and plasma catecholamines in dogs. Vet Hum Toxicol 1989; 31:149-53. [PMID: 2494798] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
The cause of death after ingestion of a large dose of paraquat is unclear. We investigated the cardiovascular effects of paraquat injection in 7 dogs that were anesthetized with urethane and alpha-chloralose and maintained on controlled ventilation. After control measurements, paraquat (20 mg/kg) was injected iv. Average concentrations of plasma paraquat were 128 micrograms/ml at 15 min (point 1) and 44 micrograms/ml at 4 hr. The average time of survival was 5.5 +/- 2.2 hr. Comparison was made of control values, 15 min (point 1), and 2.5 +/- 1.0 hr before death (point 2). Pulmonary capillary wedge pressure (+33%) and pulmonary vascular resistance (PVR) (+28%) increased, but no change occurred in mean arterial pressure (MAP) or cardiac output (CO) at 15 min. Mean arterial pressure (-50%) and cardiac output (-61%) decreased, while total vascular resistance (+56%) and PVR (+256%) were increased at point 2. Arterial pH decreased from 7.394 and 7.307 (point 1) to 7.143 (point 2). The concentration of plasma catecholamines and lactic acid increased significantly at both points 1 and 2. Renal, adrenal and myocardial tissues were studied by light and electron microscopy. The outstanding feature was early swelling of mitochondria and disruption of the contents in the presence of intact mitochondrial membrane.
Collapse
Affiliation(s)
- T Sone
- Department of Anesthesiology, Gifu University School of Medicine, Japan
| | | | | | | | | | | |
Collapse
|
50
|
Tsatsoulis A, Shalet SM, Talbot A, Robertson WR. Quantitative and qualitative changes in LH secretion following pulsatile GnRH therapy in a man with idiopathic hypogonadotrophic hypogonadism. Clin Endocrinol (Oxf) 1989; 30:167-75. [PMID: 2692879 DOI: 10.1111/j.1365-2265.1989.tb03738.x] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
The pattern of bioactive and immunoreactive LH secretion before and during pulsatile GnRH therapy (18 micrograms/90 min) in a hypogonadotrophic hypogonadal male has been studied. Before treatment the patient was azoospermic and had low testosterone (1.2 nmol/l) with low and apulsatile immunoreactive LH (1.9 +/- 0.2 IU/l) and FSH (1.4 +/- 1.9 IU/l) levels. There was no detectable LH bioactivity. During the first 24 h of GnRH therapy there was a small increase in immunoreactive (5.4 +/- 0.8 IU/l) and bioactive (6.7 +/- 1.3 IU/l) LH, with an irregular pattern and little effect on testosterone production (2.2 nmol/l). Within 1 week of treatment both bioactive (30.5 +/- 6.8 IU/l) and immunoreactive (13.6 +/- 1.5 IU/l) LH levels were above the normal range and the pattern of secretion was pulsatile. The bioactive to immunoreactive (B:I) LH ratios within the pulses (2.6 +/- 0.3) were higher (P less than 0.01) than between pulses (1.97 +/- 0.1) and the testosterone concentration (17.8 +/- 2.1 nmol/l) was now normal. At one month LH secretion was similar and testosterone pulses of high amplitude were evident corresponding to high-amplitude bioactive LH pulses. By 3 months mature spermatozoa (1.3 x 10(6)/ml) were seen in the patient's semen. The pattern of LH secretion was pulsatile but the levels of bioactive (13.1 +/- 3.6 IU/l) and immunoreactive (9.5 +/- 1.3 IU/l) LH decreased towards the normal range reflecting maturation of the testicular feedback control at the pituitary level. This effect was more pronounced on bioactive rather than immunoreactive LH secretion (57% vs 32% relative decrease). At 6 months LH levels were similar and the sperm count was normal (34 x 10(6)/ml).
Collapse
Affiliation(s)
- A Tsatsoulis
- Department of Endocrinology, Christie Hospital, Manchester, UK
| | | | | | | |
Collapse
|